← Home
MDR transitionGreener healthcarePortfolio continuity

Reusable surgical instruments: a market being reshaped

The MDR and the push for greener healthcare are changing Europe's instrument market at the same time. For manufacturers, importers, brands, procedure-pack producers and hospitals that act early, this is a real opportunity. We help you see where you stand, choose your route and get it done.

Start with a portfolio scan Talk to the founders
Why now

Portfolios are being reviewed. The first movers win.

Under the MDR, reusable surgical instruments (Class Ir) need a notified body to assess their reprocessing. Single-use instruments are medical devices too — often in a higher class than expected — and a procedure pack is only as compliant as every instrument in it. Across Europe, portfolios are now being reviewed: what continues, what changes, what stops.

At the same time, hospitals are under pressure to cut waste. Reusable instruments are part of the answer — but only if they stay available and compliant.

  • Secure your portfoliobefore competitors do, and become the reliable choice for buyers.
  • Replace what's at riskwith qualified alternatives, while others are still searching.
  • Choose between reusable and single-usebased on the facts: cost, classification, reprocessing and user preference.
  • Help hospitals meet their green targetswith reusable solutions, including in procedure packs, where workflow and total cost add up.
Good to know early
  • 26 May 2027 — UDI on the instrument itselfReusable Class I instruments placed on the market under the MDR must, in principle, carry their UDI directly on the instrument.
  • 31 December 2028 — end of legacyFrom then on, legacy instruments can only be placed on the market with an MDR certificate — and only if the transition conditions were met in 2024. Notified-body capacity takes planning.
  • Private label — your name, your responsibilitySelling under your own name can make you the legal manufacturer.
How we work

We check. We don't assume.

A catalogue or a registration alone proves little. For every product that matters, we look at the label and UDI, the EU declaration of conformity, the reprocessing instructions and — for Class Ir — the notified-body certificate and its scope. That's how you get conclusions you can act on.

Who we work with

For everyone in the chain

Manufacturers

Inside and outside the EU: choose your route to Europe and keep the evidence your customers ask for up to date.

Importers, distributors & brands

Know which product families are at risk before it affects your sales.

Procedure-pack producers

Keep track of the status of, and changes to, every instrument in your packs.

Hospitals & purchasers

Ask the right questions and spot supply risks early.

How we help

Start small, decide fast, grow together

Start here

Portfolio Continuity Scan

For each product family: manufacturer, registrations, certificates and scope, economic-operator roles, labelling and supplier dependencies. You get priorities and decision points — as a one-off scan or ongoing monitoring.

Then

Product Continuity Route

One product family at risk? We compare your options — continue, remediate, replace, change roles or phase out — and make the chosen route happen. Not a referral, but a decision you can act on.

When it fits

Partnering for the long term

From managing your technical documentation to taking on a formal role in your European supply chain — wherever governance, control and commitment are right on both sides.

Making, importing or buying reusable instruments for Europe?

Let's look at your portfolio together — directly with the founders.

Start with a portfolio scan
Generalinfo@qualinq.com